TraumaGel, a cutting-edge, plant-based hydrogel, has just received FDA approval for its remarkable ability to rapidly stop severe bleeding from traumatic injuries like gunshot wounds and stabbings.
Upon application, the gel forms an immediate barrier over the wound, triggering natural blood clotting within seconds—no pressure or bandages required.
Developed by Cresilon, TraumaGel is designed for quick and easy use in high-stress environments, such as battlefields or emergency situations, and promises to revolutionize trauma care by saving lives when every second counts.
Innovations like this are reshaping the medical landscape, making treatments faster, safer, and more efficient.
The future of healthcare is here, and its impact has never been greater.
See video here
